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We undertook the molecular cloning of porcine thyroid peroxidase (TPO). Four oligonucleotide probes 
were synthesized on the basis of amino acid sequences of 3 tryptic peptides from highly purified porcine 
TPO. These probes were used to screen a pig thyroid cDNA library. Seven of 16 selected clones (0.451.15 
kb in size) reacted with all 4 probes. Nucleotide sequencing of the 1.15 kb at the 3’-end of the structural 
gene revealed the complementary sequence to all 4 probes as well as the nucleotides coding for the entire 
length of the 3 tryptic peptides. There is an open reading frame of 332 amino acid residues. On Nothern 
blot analysis this gene codes for an mRNA species of 2.85 kb, corresponding to the anticipated size of the 
mRNA for the intact TPO molecule. We have therefore cloned and characterized a cDNA clone ceding 
for approx. 36% of porcine thyroid peroxidase. 
Thyroid Peroxidase CD NA clone 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Thyroid peroxidase (TPO) is a hemoprotein 
whose purification has been difficult because it is 
membrane-bound and therefore requires 
solubilization with detergent and limited trypsin 
digestion [l-5]. For these reasons there has been 
considerable disagreement in the literature as to 
some of its basic properties. For example, 
estimates of its molecular mass have varied be- 
tween 45 and 104 kDa (discussed in [1,6]). Recent 
purification of TPO using monoclonal antibodies 
without tryptic digestion suggests that in its native 
state the enzyme is present as a single polypeptide 
of about 100 kDa and may exist as a 400 kDa 
tetramer [7]. 
2.1. Construction of pig thyroid cell cDNA library 
The oligo(dT)-primed pig thyroid cell cDNA 
library was constructed in h gtll essentially as 
described by Ebina et al. [8], with minor modifica- 
tions, using mRNA prepared [9,10] from primary 
cultures of pig thyroid cells stimulated with 
25 mu/ml TSH for 2 days. Double-stranded 
cDNA was ligated into the EcoRI site of A gtl 1 [ 1 l] 
(Vector Cloning System, San Diego, CA) with a 
yield of 1.26 x lo6 recombinant clones, followed 
by amplification in Y1088 cells [ll]. The average 
size insert (n = 10) was 0.93 kb. 
The molecular cloning of TPO would represent 
a major advance in efforts to characterize 
definitively this important thyroid enzyme. Here, 
we report the cloning and characterization of a 
1.15 kb cDNA clone for the 3 ‘-end of porcine 
TPO. 
2.2. Oligonucleotide probe synthesis and 
screening 
Preparation of the purified porcine TPO used 
for amino acid analysis was described previously 
[4]. Estimated purity was 71-84% based on a com- 
parison of the &ie/A~s~ ratio to a preparation 
shown by polyacrylamide gel electrophoresis to be 
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80-95% pure. 100,ug was provided to Dr Craig 
Miles of the National Jewish Center for Im- 
munology and Respiratory Medicine, Denver, GO, 
who performed the amino acid analysis, tryptic 
digestion, HPLC purification of these fragments 
and amino acid sequencing of selected fragments 
[ 121. The oligonucleotide probes were synthesized 
according to our specifications by the 
Biomolecular Resource Center, University of 
California, San Francisco. 
The oligonucleotide probes were end-labeled 
with [T-~~P]ATP (New England Nuclear, Boston, 
MA) to a specific activity of about 1-2/tCi/pmol 
[ 131. Screening was performed according to stan- 
dard techniques 1131. Hybridizations were con- 
ducted for 2- 16 h at 42°C in 6 x SSC buffer 
(150 mM NaCl, 15 mM Na citrate, pH 7.0), 
10 mM EDTA, 5 x Denhardt’s solution, 0.5oio Na 
lauryl sarcosine, 0.1 mM ATP and 1 .O mg/ml 
tRNA. Final rinses (20 min each) were at 42°C 
(twice) and at 48°C (once) in 6 x SSC, 0.1% Na 
lauryl sarcosine. Autoradiographs were performed 
at -70°C using Kodak XAR-5 film. 
2.3. Subcloning and DNA sequencing 
cDNA inserts were released by EcoRI digestion 
(10 U/&g DNA; Boehringer Mannheim, In- 
dianapolis, IN) and ligated into EcoRI-cut pUC18 
or M13. Dideoxynucleotide sequencing was per- 
formed using 4-6070 denaturing polyacrylamide 
urea gels [14]. 
, I I / / 
35 40 45 50 55 60 
MINUTES 
Fig.1. Tryptic peptides of purified pig thyroid TPO, 
lOOlag purified TPO was subjected to tryptic digestion 
followed by HPLC [ 161. Three hydrophobic peptides (A 
eluting at 47.02 min, B at 47.70 min, and C at 
59.67 min) were chosen for amino acid sequence 
anaIysis. 
2.4. Northern blot analysis 
1Opg poly(A~)-mRNA from pig thyroid tissue 
was electrophoresed in 1% agarose using for- 
maldehyde [ 13 I, blotted onto nitrocellulose paper 
and probed with a [32P]dCTP nick-translated por- 
cine TPO cDNA. 
3. RESULTS 
3.1. Cloying of TPU re~o~bina~ts u&g 
oiigonucleotide probes 
We first screened the A gtl 1 expression library 
using rabbit antiserum to porcine TPO prepared 
PROBE A PEPTIDE~ ABINO AC& 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 B PHE TRP TRP GLU ASN PRO GLY VAL PHE THR GLU ALA GLN ARG 
AA; ACC ACC CT; TTr; GGfN) CC 
2 A VAL GLY GLN TRP PRO GLN GLU PHE GLU PRO CYS ALA SER ILE GLN GLY MET 
GTE ACC GGW GT; CT; AA; CT; GG 
3 GTG GGC CAG TGG CCC CAG GAG TTC GAG CCC TGC GCC TCC ATC --- GGC ATG 
4 C ALE LEU Gtu LEU TYR GLN tits PRO (BLA) ASN ILE &A) VAL TRP LEU 
TAG GAC CCG GAC AT; GTC' GT; GG 
Fig.2. Oligonucleotide probes synthesized on the basis of TPO tryptic peptides A-C (see fig.1). Probes 1, 2 and 4 are 
anticodon sequences; probe 3 the codon sequence. Two nucleotides at one position indicate that both were synthesized. 
BLA (Blank) indicates that this residue could not be identified, probably because of derivatization. 
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previously by one of us (A.T.). However this ap- 
proach was unsuccessful because all clones also 
reacted with preimmune serum, though not with 
normal rabbit serum. We therefore turned to syn- 
thesizing oligonucleotide probes. After tryptic 
digestion of highly purified porcine TPO three 
hydrophobic peptides from the HPLC profile 
(A-C) were chosen on the basis of their strength of 
signal and good separation from adjacent peaks 
(fig. 1). Based on these peptides, 4 oligonucleotide 
probes were synthesized (fig.2) according to the 
following strategies. Probe 1 (20-mer) and probe 2 
- S”4 
-2.2 
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(23-mer) consisted of all possible permutations (32- 
and 128-fold degeneracies, respectively). For probe 
3, we synthesized a single species of greater length 
(48-mer) using the nucleotide of greatest frequency 
in degenerate codons 1151. Probe 4 (23-mer) was 
synthesized using a combined approach. Thus for 
4 amino acid residues, 11 nucleotides containing all 
possible permutations were selected (degeneracy of 
8). For the remaining 4 amino acids the nucleotides 
of greatest frequency were chosen. 
Screening 1.1 x lo5 recombinant plaques in the 
library with probe 4 yielded 20 clones. EcoRI 
digests of DNA from 12 of these clones were sub- 
jected to Southern blot analysis (fig.3), confirming 
the specificity of the interaction of the 
oligonucleotide probe with the cDNA inserts. In- 
serts in clones D, H and P apparently had two 
fragments, representing either an EcoRI site, or 
the cloning of more than one cDNA fragment into 
the same vector. As expected, only one fragment 
reacted with probe in these clones. To test whether 
probes l-3 would hybridize to probe 4-selected 
clones, and also to obtain information on the 
possible interrelationships between these clones, 16 
clones were tested in a confluent plaque spot assay 
kb 
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Fig.3. Agarose gel electrophoresis and Southern blot 
analysis of EcoRI digests of probe 4 positive clones. 
Phage DNA from 12 of the probe 4 positive clones 
(B-P) was digested with EcoRI and electrophoresed in
1.2% agarose, along with Hind111 digests of wild-type 
bacteriophage h DNA and bacteriophage PM2 DNA as 
molecular mass markers. After staining with ethidium 
bromide for visuaIization (lower panel), the DNA was 
blotted onto nitrocellulose paper, hybridized with probe 
4 as described in section 2, and autoradiographed (upper 
panel). 
Fig.4. Northern blot analysis of pig thyroid cell mRNA 
(1Opg) using the cDNA insert (0.6 kb) of clone M as a 
probe. Molecular size markers (1 kb ladder, BRL, 
Gaithersburg, MD) are shown on the right, and 16 S and 
23 S ribosomal markers are shown on the left. 
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(A) AA 
1 10 20 30 
Phe Cys Gly Leu Ser AZ-~ Leu Glu Thr Trp Ala Asp Leu Ser Ala Ala Thr Ala Asn Gly Arg Val Ala Asp Ar8 Ile Jav Gly Lau Tyr 
TTC TGC GGC CTG TCC AGA CTC GAG ACC TGG GCC GAC CTG AGT GCT GCC ACT GCC AAC GGG CGT GTG GCC GAG AGG ATC CM; GGC CTG TAG 
40 50 60 
Gln His Pro Asp Asn Ile Asp Val Trp Leu Gly Gly Leu Ala Glu Ser Phe Leu Pro Gly Ala Arg Thr Gly Pro Leu phe Ala Cys Ile 
CAG CAT CCC CAT MC ATT GAC GTC TGG CTG GGC GGC TCG GCC GAG AGC TTC CTC CCT GGG GCG CGG ACC GGC CG CTG ‘ITC Gtx TGG ATC 
70 80 90 
Ile Gly Lys Gln Met At8 Ala Leu Arg Asp Gly Asp Ar8 Phe Trp Trp Glu Am Pro Gly Val Phe Thr Glu Ala Gln Ar& Arg Glu Leu 
ATC GGA AAG CAG ATG AGG GCC CTG AGG GAC GGC GAC CGG TTC TGG TGG GAG AAC CCG GGG G'lG Tl'C ACA GM GCC CAG AGG CGC GAG CTG 
100 110 120 
Ser Arg His Ser Wet Ser Arg Val Ile Cys Asp Asn Ser Gly Leu Ser His Val Pro Lea Asp Ala Phe Arg Val Gly Gin Trp Pro Gin 
AGC CGG CAC TCT An; XC CGC GTC ATC TGC GAG MC AGC GGC CTG TCC CAC GTG CCC CTT GAT GCC lTC CGG@ Gl% CAG TfX CCT CAG 
. 
130 140 150 
Glu Phe Glu Pro Cys Ala Ser Ile Gln Gly Met Asp Lsu Gly Ala Trp Arg Glu Ala Pro Pro Ser Gly Asp Ala Cys Gly Phe Pro Asp 
GAG TTC GAG CCC TGT CCC AGC ATC GAG WC ATG GAC CTG GGC CCC TGG AGG GAG GCC CCT CCC TCA GGG GAC GCG TGT GGC TTC CCG AC 
160 170 180 
Pro Val Glu Asp Gly Gly Phe Leu Leu Cys Glu Glu Arg Gly Gln Arg Val Lea Val Phe Ser Cys Arg His Gly Phe At& Leu Arg Gly 
CCA GTG GM GAC GGG GGC TX CTG CTC TGT GAG GAG CGT GGC CAG CGC GTG CTG GTG ill' TCC TGT CGT CAC GGG lTC CGG CTC CGA GGA 
190 200 210 
Pro Ala Gin Ile Thr Cyr Thr Pro Arg Gly Trp Asp Ser Pro Pro Pro Leu Cys Lys Asp Ile Am Glu Cys Glu Asp Glu Tht Asp Pro 
CGA GCG GAG ATC ACC TGC ACC CCC CGA GGG TGG GAC TCC CCG CCC CCC CTC TGT MA GAC An: MC GAG TGT GM GAG GAG ACA GAG CCT 
220 230 240 
Pro Cys His Ala Ser Ala Arg Cys Lys Asn Thr Lys Gly Gly Val Leu Cys Glu Cys Sac Asp Pro Leu Val Leu Gly Glu Asp Gly At8 
CCC TGC CAC CCG TCT CCC CGG TGC AAG MC ACC AAG CGT GGC GTC CTG TGC GAG TCC TCG GAC CCT CTC GTG CTC GGG GAG GAC GGC AGG 
250 260 270 
Thr Cys ‘Ural Asp Ala Gly Arg Leu Pro Arj3 Ala Ser Val Val Ser Ile Ala Leu Gly Ala Val Leu Val Cys Gly Lau Ala Gly lau Ala 
ACC TGC GTE GAT CCC CGG AGG CTC CCG CCC GCG TCT GTG GTC TCC ATC GCG CTG ffiC GCC GTG CTC GTC TGC GGC CTC GCA GGC CTC GCC 
280 290 300 
Trp Thr Val Val Cys Arg Trp Thr His Ala Asp Ala Arg Pro La Leu Pro Val Gly Glu Gly Glu Cly Asp Gly Lys Ser Pro Ser Leu 
;rGG ACG GTG Gil' TGC AGG TGG ACA CAC GCG GAT GCC AGG CCC ll'G CTG CCC GTC GGG GAG GGA GAA GGA GAG GZG AAh AGC CCC TCC CTG 
310 320 330 
Pro Leu Pro Gly Cys Gly Asn Aq Arg Asp Val Gly Ala Ala Pro Ala Leu Glu Val Glu Gin Asp Leu Ser Cys Gly Ser Arg Gly Leu 
CCG CTG CCC GGA TGC GGG MC CGC CCC GAT GTG CCC GCT GCT CCC GCT CTG GAG GTG GAG CAG GAC CTG AGC XT CGA TCC CGA GGC CTC 
Cys Glu 
TGC GAG TACGMCCAGCCTGTGTGCCACACGn;CTGCCCGCA~CAGA~CAGA~CCACCC~GTGC~C~ACA~CA~G~~~A~A~AT~~~ 
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Fig.5. (A) Nucleotide sequence of the 3’-end of porcine TPO cDNA. Peptides A-C are underlined with solid lines. 
(B) Sequencing strategy employed. Three different clones (J,B,M) were used to obtain the sequence in both directions 
of this region of the structural gene. E, EcoRI; S, Suu3A; A, AfuI; M, MluI; Bal, BatI; H, HueIII; B, BarnHI. 
using all 4 probes (not shown). Seven clones 
reacted with all 4 probes. None of the 4 probes 
hybridized to any of 5 control clones. 
3.2. Confirmation of TPO cloning by nucleotide 
sequencing 
The cDNA in one 1.15 kb clone (J) that reacted 
with all 4 probes was sequenced (figSA) according 
to the strategy shown in fig.SB. Two smaller clones 
(B, M) which contained identical 5 ‘-ends to clone 
J but were of shorter length were used to complete 
the sequencing in both directions of the 1.15 kb at 
the 3 ’ -end of the structural gene. There is an open 
reading frame of 332 amino acids followed by an 
untranslated region of 146 bp prior to the poly(A) 
tail. The AATAAA polyadenylation signal begins 
20 bp upstream of the poly(A) tail. The com- 
plementary sequence to all 4 probes was con- 
firmed, and the perfect homology with probe 4 
explained the success with this probe. Most impor- 
tant, however, was that the nucleotide sequence 
flanking the site of hybridization of all of the 
probes conformed exactly to the anticipated 
sequence based on the tryptic peptides. The two 
indeterminate amino acids in peptide C were iden- 
tified as aspartic acid, which might be anticipated 
because of their propensity to derivatization. In- 
terestingly, the nucleotide sequence coding for the 
amino acids in peptide C revealed an unexpected 
Gln at residue 15 that was not used in the synthesis 
of probe 3. On reviewing the amino acid sequenc- 
ing data, the missing Gln cycle was indeed present 
but had inadvertently not been recorded. Northern 
blot analysis of porcine thyroid mRNA using the 
cDNA insert (0.6 kb) of clone M as a probe re- 
vealed a single mRNA species of 2.85 kb (fig.4). 
4. DISCUSSION 
The nucleotide sequence of the 1.15 kb cDNA 
clone that reacts with all 4 probes indicates un- 
equivocally that we have cloned part of the protein 
from which the amino acid sequence was derived, 
namely porcine TPO. The TPO subjected to amino 
acid sequencing was of high purity (approx. 80%), 
with no discrete bands other than the enzyme being 
observed on polyacrylamide gel electrophoresis 
[4], and the tryptic fragments selected following 
HPLC separation were discrete. 
Further support that the cDNA clone that we 
have isolated is indeed TPO is provided by the 
Northern blot analysis that revealed a single 
mRNA species of 2.85 kb. After subtraction of the 
nucleotides at the untranslated 3 ‘-end, it can be 
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deduced that this mRNA species codes for a pro- 
tein of approx. 107 kDa in size. This size cor- 
responds to the approx. 100 kDa size of intact 
porcine TPO 171. An important conclusion from 
our data, therefore, is that TPO is synthesized as 
a single peptide. The ‘subunits’ previously ob- 
served [4] can probably be attributed to cleavage 
by trypsin during the purification of the enzyme. 
The nucleotide sequence of 1.15 kb of the 
3 ‘-end of porcine TPO reveals an open reading 
frame of 332 amino acid residues. This would ac- 
count for a polypeptide of about 36 kDa, approx. 
36% of the native nzyme 171. None of the clones 
that we isolated from our library contain the entire 
structural gene. This is not too surprising consider- 
ing that our library was constructed using an 
oligo(dT) primer which would bias our recom- 
binants to the 3’-end of the gene. In addition, the 
average length of our cDNA inserts was only 
0.95 kb. 
The isolation of a cDNA clone containing part 
of the porcine TPO structural gene will now permit 
the cloning and sequencing of the entire TPO gene 
in the pig, as well as in other species. This 
knowledge will in turn lead to a better under- 
standing of: (i) the structure Andy mechanism of ac- 
tion of TPO, and the identification of possible 
alterations in the TPO genome in various thyroid 
disorders; (ii) the mechanism by which TSH 
regulates TPO expression in thyroid cells [16,17]; 
and (iii) the relationship between TPO and the 
microsomal antigen in Hashimoto’s thyroiditis 
[l&19]. 
ACKNOWLEDGEMENTS 
This work was supported by NIH grants 
AM 36182 and 19289 as well as by the Veterans 
Administration. We greatly appreciated helpful 
discussions with Drs Walter L. Miller, Bon-Chu 
Chung, Karla J. Matteson, Charles Craik and 
Craig Miles. The expert secretarial assistance of 
Jan Alfstad is gratefully acknowledged. 
REFERENCES 
[1] DeGroot, L.J. and Niepomniszcze, H. (1977) 
Metabolism 26, 665-718. 
f2] DeGroot, L.J. and Davis, A.M. (1962) 
Endocrinology 70, 505-510. 
[3] Alexander, N.M. (1977) Endocrinology 100, 
1610-1620. 
[4] Rawitch, A.B., Taurog, A., Chernoff, S.B. et al. 
(1979) Arch. Biochim. Biophys. 194, 244-257. 
[SJ Ohtaki, S., Nakagawa, H., Nakamura, M. et al. 
(1982) J. Biol. Chem. 257, 761-766. 
[6] Ohtaki, S., Nakagawa, H., Nakamura, S. et al, 
(1985) J. Biol. Chem. 260,*441-448. 
[7] Nakagawa, H., Kotani, T., Ohtaki, S. et al. (1985) 
Biochem. Biophys. Res. Commun. 127, 8-14. 
[8] Ebina, Y., Ellis, L., Jarnagin, K. et al. (1985) Cell 
40, 747-758. 
[9] Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. 
et al. (1979) Biochemistry 18, 5294-5299. 
[IO] Cathala, G., Savouret, J., Mendez, B. et al. (1983) 
DNA 2, 329-335. 
[ll] Huynh, T.V., Young, R.A. and Davis, R.A. (1984) 
in: DNA Cloning Techniques: A Practical 
Approach (Glover, D. ed.) pp.49-78, IRL, 
Oxford. 
WI 
1131 
1141 
WI 
1161 
[I71 
D81 
u91 
Hannum, C.H., Kappler, J.W., Towbridge, I.S. et 
al. (1984) Nature 312, 65-67. 
Maniatis, T., Fritsch, E.F. and Sambrook, J. 
(1982) Molecular Cloning, A Laboratory Manual, 
Cold Spring Harbor Laboratory, Cold Spring 
Harbor, NY. 
Sanger, F., Nicklen, S. and Coulson, A.R. (1977) 
Proc. Natl. Acad. Sci. USA 74, 5463-5467. 
Grantham, R., Gautier, C., Gouy, M., Jacobzone, 
M. and Mercier, R. (1981) Nucleic Acids Res. 9, 
r43-r74. 
Magnusson, R.P. and Rapoport, B. (1985) 
Endocrinology 116, 1493-1500. 
Nagasaka, A. and Hidaka, H. (1980) Biochem. 
Biophys. Res. Commun. 96, 1143. 
Portmann, M.D., Hamada, N., Heinrich, G. et ai. 
(1985) J. Clin. Endocrinol. Metab. 61, 1001-1003. 
Czarnocka, B., Ruf, J., Ferrand, M., Carayon, P. 
and Lissitzky, S. (1985) FEBS Lett. 190, 147-152. 
396 
